Comparison on Clinicopathological Features and Prognosis between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China

Medicine (United States)

Volumn 94, Issue 34, 2015, Pages e1386-

  Liu, Kai ^a   Zhang, Weihan ^a   Chen, Xiaolong ^a   Chen, Xinzu ^a   Yang, Kun ^a   Zhang, Bo ^a   Chen, Zhixin ^a   Zhou, Zongguang ^a   Hu, Jiankun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ANASTOMOSIS LEAKAGE; ARTICLE; BODY MASS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISTAL GASTRIC ADENOCARCINOMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRIC JUNCTIONAL ADENOCARCINOMA; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; STOMACH ADENOCARCINOMA; STOMACH PARESIS; SURVIVAL RATE; TUMOR VOLUME; ADENOCARCINOMA; ADVERSE EFFECTS; AGE; AGED; CHINA; COMPARATIVE STUDY; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGE FACTORS; AGED; CHINA; COHORT STUDIES; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR BURDEN;

EID: 84944904961     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001386     Document Type: Article

References (32)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
3. Stein HJ, Feith M, Siewert JR. Cancer of the esophagogastric junction. Surg Oncol. 2000;9:35-41.
4. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol. 2002;14:107-113.
5. Zhou Y, Zhang Z, Zhang Z, et al. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18-25.
6. Ryu KW, Kim CS, Goo BH. Clinicopathologic characteristics of and prognosis for proximal gastric carcinomas. J Korean Surg Soc. 2000;59:223-228.
7. Pohl H, Welch HG. The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Nat Cancer Inst. 2005;97:142-146.
8. Craanen ME, Dekker W, Blok P, et al. Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastro-enterol. 1992;87:572-579.
9. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644-651.
10. Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach: results and comparisons to distal adenocarcinoma of the stomach. Ann Surg. 1997;225:678-685.
11. Kim DY, Joo JK, Ryu SY, et al. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia. Dig Surg. 2006;23:313-318.
12. Kunisaki C, Akiyama H, Nomura M, et al. Surgical outcomes for early gastric cancer in the upper third of the stomach. J Am Coll Surg. 2005;200:15-19.
13. Stark SP, Romberg MS, Pierce GE, et al. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg. 1996;171:478-482.
14. Cushieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996;347:995-999.
15. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745-748.
16. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457-1459.
17. Zhang H, Wang W, Cheng Y, et al. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China. World J Surg Oncol. 2013;11:155.
18. Bai JG, Lv Y, Dang CX. Adenocarcinoma of the esophagogastric junction in China according to Siewert's classification. Jpn J Clin Oncol. 2006;36:364-367.
19. Liu K, Yang K, Zhang WH, et al. Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988-2012: a single-institution, high-volume experience in China. Ann Surg. 2015[Epub ahead of print]. DOI: 10.1097/SLA.0000000000001148.
20. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101-112.
21. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
22. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarci-noma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1000.
23. Ajani JA, Bentrem DJ, Besh SD, et al. Gastric cancer, version 2. J Natl Comprehensive Cancer Netw. 2013;11:531-546.
24. Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esoph. 1996;9:173-182.
25. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1, 002 consecutive patients. Ann Surg. 2001;232:353-361.
26. Bruno L, Nesi G, Montinaro F, et al. Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol. 2000;74:33-35.
27. Jang JH, Beron RI, Ahn HS, et al. Clinicopathological features of upper third gastric cancer during a 21-year period (single center analysis). J Gastric Cancer. 2010;10:212-218.
28. Piso P, Werner U, Lang H, et al. Proximal versus distal gastric carcinoma-what are the differences? Ann Surg Oncol. 2000;7: 520-525.
29. Maeda H, Okabayashi T, Nishimori I, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg. 2008;206:306-310.
30. McColl KE. Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol. 2006;20:687-696.
31. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. 1st ed. Lyon, France: IARC Press. 2000, 281-292.
32. Ectors N, Driessen A, De Hertog G, et al. Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarci-noma? Arch Pathol Lab Med. 2005;129:183-185.